Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 27-May-2022 titled acquisition of UractivTM Portfolio from Fiterman Pharma in Romania
Nila Infrastructures Limited has informed the Exchange about Board Meeting held on 27-May-2022 to consider Other business matters
Hemisphere Properties India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.
Cravatex will hold a meeting of the Board of Directors of the Company on 30 May 2022
Subros announced that the Board of Directors of the Company at its meeting held on 24 May 2022 inter alia have recommended the final dividend of Rs 07 per equity Share ie 35Percentage subject to the approval of the shareholders
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
